MedTrace Logo

Vision Improvement for Patients With Age-Related Macular Degeneration

NCT04268836 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-03-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether the Optimal Acuity Clear-K® Low Vision Aid System provides a safe and effective treatment to improve vision for patients with age-related macular degeneration.

Conditions

  • Age-related Macular Degeneration

Interventions

DEVICE

Optimal Acuity Clear-K® Low Vision Aid System treatment

The treatment involves irradiation of the cornea with low energy light in a treatment pattern that produces corneal shape change.

Sponsors & Collaborators

  • Bochner Eye Institute

    collaborator UNKNOWN

  • Optimal Acuity Corporation

    lead INDUSTRY

Principal Investigators

  • Michael Berry, PhD · Optimal Acuity Corporation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-09
Primary Completion
2024-05-31
Completion
2025-05-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04268836 on ClinicalTrials.gov